Variant report
Variant | nsv432115 |
---|---|
Chromosome Location | chr20:24871385-24915839 |
allele | n/a |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:24879800-24881400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr20:24880600-24880800 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr20:24880600-24881200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr20:24880600-24881200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr20:24880800-24881000 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
6 | chr20:24881200-24890200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr20:24890200-24891400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr20:24891000-24891200 | Weak transcription | Spleen | Spleen |
9 | chr20:24891200-24891400 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
10 | chr20:24891400-24893600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr20:24891800-24892200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr20:24891800-24892600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr20:24891800-24896000 | Weak transcription | Spleen | Spleen |
14 | chr20:24892000-24892800 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
15 | chr20:24892200-24892400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
16 | chr20:24892200-24892600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr20:24892600-24898600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr20:24893600-24893800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
19 | chr20:24893600-24894000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr20:24894000-24898400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr20:24894600-24894800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
22 | chr20:24895200-24895600 | Bivalent Enhancer | Fetal Stomach | stomach |
23 | chr20:24895400-24895800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
24 | chr20:24895800-24898400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
25 | chr20:24896000-24896800 | Active TSS | Spleen | Spleen |
26 | chr20:24898000-24899600 | Enhancers | Brain Hippocampus Middle | brain |
27 | chr20:24898400-24899800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
28 | chr20:24898400-24900600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
29 | chr20:24898600-24898800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
30 | chr20:24898600-24898800 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
31 | chr20:24898600-24898800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
32 | chr20:24898600-24898800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
33 | chr20:24898600-24899000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
34 | chr20:24898600-24899000 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
35 | chr20:24898600-24899200 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
36 | chr20:24898600-24899600 | Enhancers | H1 Cell Line | embryonic stem cell |
37 | chr20:24898600-24899600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
38 | chr20:24898600-24899800 | Enhancers | Fetal Lung | lung |
39 | chr20:24898600-24899800 | Bivalent Enhancer | Fetal Stomach | stomach |
40 | chr20:24898600-24899800 | Enhancers | GM12878-XiMat | blood |
41 | chr20:24898600-24900000 | Enhancers | Adipose Nuclei | Adipose |
42 | chr20:24898600-24901400 | Enhancers | Placenta | Placenta |
43 | chr20:24898800-24899000 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
44 | chr20:24898800-24899000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
45 | chr20:24898800-24899000 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
46 | chr20:24898800-24899000 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
47 | chr20:24898800-24899000 | Flanking Bivalent TSS/Enh | Fetal Muscle Trunk | muscle |
48 | chr20:24898800-24899200 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
49 | chr20:24898800-24899200 | Enhancers | Primary B cells from peripheral blood | blood |
50 | chr20:24898800-24899200 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |